Implementation strategy for reducing diabetes, cardiac and renal complications in people with type 2 diabetes (GP Prompt)
What we are doing:
We are developing and testing a method of reducing heart and kidney complications in people with type 2 diabetes and microalbuminuria. If successful this will reduce mortality and symptoms, reduce in-patient costs and improve quality of life. The study will install a customised software package on practice databases which will flag patients with type 2 diabetes and microalbuminuria who are not meeting targets for blood pressure, total cholesterol or long-term blood sugar levels. The health care professional will use it to take them to a treatment algorithm and information sheet.
Why are we doing it:
People with type 2 diabetes and microalbuminuria are at high risk of heart and kidney disease. Early identification can mean earlier treatment, better outcomes and improved long-term health. However, there is currently no routine way for GPs and practice nurses to review all the risk factors that they need to consider. The new ‘prompting’ software will bring these factors together and alert healthcare professionals that the patient is at high risk of heart and kidney disease. The healthcare professional can then target the many risk factors involved in order to improve heart and kidney outcomes.
What the benefits will be:
The study aims to show that patients cared for by practices receiving additional training and using the computerised ‘prompting’ system will have better health outcomes. If this is the case, the evidence will be used to recommend that all GP surgeries are provided with this training and information to improve patient outcomes and quality of life and decrease costs by reducing medications and hospital visits.
Who we are working with:
This project has been developed in collaboration with a number of partners across the health community including:
- Leicester City CCG
- Leicestershire County CCGs
- PRIMIS, University of Nottingham
- East Midlands Academic Health Science Network (EMAHSN)
- Health Education East Midlands (HEEM)
- 24 GP practices from Leicester and Leicestershire
- Boehringer Ingelheim and Lilly
- University of Leicester
- MSD Ltd
Professor Kamlesh Khunti, Professor of Primary Care Diabetes & Vascular Medicine, University of Leicester
Carol Akroyd, email@example.com